Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117416) titled 'A Prospective, Single-Center, Single-Arm Phase II Open-Label Study of QL1706 in Unresectable Locally Advanced or Metastatic Urothelial Carcinoma Previously Treated with Platinum-Based Chemotherapy, PD-(L)1 Inhibitors, and With or Without ADC Therapy: Efficacy and Safety Outcomes' on Jan. 23.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Sun Yat-sen University Cancer Center
Condition:
Urothelial carcinoma
Recruitment Status: Not Recruiting
Phase: 2
Date of First Enrollment: 2026-01-23
Target Sample Size: Treatment Group:33;
Countries of Recruitment:
China
To know more, vi...